Viewing Study NCT01272258


Ignite Creation Date: 2025-12-25 @ 12:18 AM
Ignite Modification Date: 2025-12-30 @ 9:47 AM
Study NCT ID: NCT01272258
Status: WITHDRAWN
Last Update Posted: 2017-02-02
First Post: 2011-01-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of Observed Long-acting, Anti-HIV Treatment With a Monoclonal CCR5 Antibody (PRO 140) as an Adjunct to a New, Optimized, Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With Viral Rebound and Documented Poor Adherence
Sponsor: CytoDyn, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module